Automate Your Wheel Strategy on ELV
With Tiblio's Option Bot, you can configure your own wheel strategy including ELV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ELV
- Rev/Share 838.1488
- Book/Share 194.2028
- PB 1.4911
- Debt/Equity 0.6904
- CurrentRatio 0.0
- ROIC 29.1255
- MktCap 65015643940.0
- FreeCF/Share 17.7192
- PFCF 16.2498
- PE 12.1633
- Debt/Assets 0.2476
- DivYield 0.0231
- ROE 0.1251
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | July 21, 2025 |
| Downgrade | ELV | Leerink Partners | Outperform | Market Perform | -- | $310 | July 18, 2025 |
| Downgrade | ELV | Robert W. Baird | Outperform | Neutral | -- | $529 | April 15, 2025 |
| Upgrade | ELV | Argus | Hold | Buy | -- | $450 | March 17, 2025 |
| Downgrade | ELV | Stephens | Overweight | Equal Weight | $520 | $440 | Jan. 22, 2025 |
| Downgrade | ELV | Argus | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Health insurer Elevance sees first-quarter profit above estimates
Published: April 17, 2025 by: Reuters
Sentiment: Positive
Elevance Health said on Thursday it expects first-quarter profit above estimates, helped by medical cost trends that were in line with its expectations.
Read More
Will a Strong MA Business Aid Elevance Health's Q1 Earnings?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
ELV's Q1 results are expected to reap the benefits of higher premiums from growing Medicare Advantage membership and acquisitions pursued within the Carelon unit.
Read More
US Health Insurance Stocks Rally After $25 Billion Federal Boost To Medicare Payments
Published: April 08, 2025 by: Forbes
Sentiment: Positive
Health insurance stocks soared Tuesday morning on the first full day of trading after the U.S. government announced a more than 5% average increase in government reimbursement rates for 2026 Medicare Advantage plans run by private insurers.
Read More
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: April 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Elevance Trades at a Bargain: Is it a Good Time to Buy ELV Stock?
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
With a strengthening commercial business, ELV is seeing steady membership growth.
Read More
Strength Seen in Elevance Health (ELV): Can Its 3.1% Jump Turn into More Strength?
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Read More
U.S. Managed Care Q4 2024 Earnings Recap: Medical Costs Continue To Mount
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Negative
US managed care insurers' fourth quarter 2024 earnings season was characterized by generally higher medical costs amid ongoing changes to federally subsidized healthcare plans that, in some cases, resulted in lower earnings per share estimates. Many of the largest publicly traded US health insurers saw their medical costs grow in the fourth quarter and full year 2024, resulting in decreased revenues and lower-than-anticipated EPS, largely in line with analyst projections. Nearly across the board, the largest publicly traded US managed care insurers saw their medical care ratios rise from 2023 as changes to Medicare Advantage and Medicaid continued to impact …
Read More
Defensive, Sector-Based Dividend Growth: 6 Opportunities And One Special Highlight (Part 1)
Published: February 23, 2025 by: Seeking Alpha
Sentiment: Positive
Dividend growth investing can offer high-quality stocks, with small dividends growing in the 10-15% range, providing impressive investment opportunities. Diversified, large-cap companies with strong revenue, earnings, and dividend growth, are reliable characteristics of such dividend growth companies investors can count on. The companies I'll highlight have strong insider holdings, reliable growing dividends, and current or potential for share buybacks, offering stability and potentially strong capital gains.
Read More
About Elevance Health Inc. (ELV)
- IPO Date 2001-10-30
- Website https://www.elevancehealth.com
- Industry Medical - Healthcare Plans
- CEO Gail Koziara Boudreaux
- Employees 104200